Class III · Lower riskRecall completed
Bortezomib
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot # H210233, Exp 3/1/2023
Where it was soldUSA Nationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed stability specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 43598-865-60 |
Show the full FDA record
| Full product label | Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-865-60 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | USA Nationwide |
| Quantity | 2,980 vials |
| Recall initiated | 2022-01-19 |
| Report date | 2022-03-02 |
| Recall completed | 2022-12-13 |
| Recall number | D-0577-2022 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.